Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
Latest Headlines
J&J Backs Motion to Dismiss ERISA Lawsuit, Says It Couldn’t Have Made Corrective Disclosures in Fiduciary Capacity
Johnson & Johnson Defendants Seek Permission to Appeal Order Reinstating Talcum Powder Claims in N.J. High Court
Parties in N.J. Talcum Powder State Court Litigation File Joint Status Report
Bankruptcy Court Approves Sale of Imerys Talc America to Magris Resources Canada Inc.
Parties in Talcum Powder Ovarian Cancer MDL Docket File Status Report
Missouri Supreme Court Won’t Hear Appeal of Multi-Billion Talcum Powder Verdict
